Skip to content

Team

flerie-ted-people

Ted Fjällman

Chief Executive Officer
Member of the Management team

Ted Fjällman

Ted has been CEO of Flerie since January 2023, previously having been Partner, Venture Partner and the CEO of portfolio company Prokarium. He is board member of several drug development companies and was the first CEO of NorthX Biologics after Flerie acquired a manufacturing facility from Charles River to set up this CDMO.

Ted has previously worked in clinical research and strategy consulting and holds a PhD in Molecular Biology from the University of Guelph, Canada. He has served as committee member of the UK BioIndustry Association (BIA) and on the Management Board of the international Bacterial Vaccines Network (BactiVac). He also co-founded Tekiu, a knowledge transfer broker active internationally.

He enjoys travelling, cultural exchanges and languages and splits his time between Switzerland, Sweden and the UK.

 

Ted on Linkedin

Cecilia Schéele

Chief Financial Officer
Member of the Management team

Cecilia Schéele

Cecilia has been CFO of Flerie Invest since 2021 and deputy CEO since 2023. She has more than 20 years of experience in finance from various positions at Reci­pharm AB (publ), KPMG, and working with the IPO of Viva Wine Group. She has a MSc in International Business Administration from Lund University.

Cecilia enjoys spending time with family and friends over a meal, hiking, and heading to her cottage in southern Närke.

 

Cecilia on Linkedin

flerie-mark-people

Mark Quick

Partner
Member of the Management team

Mark Quick

Mark joined Flerie in 2022 as a Partner having previously worked at Recipharm where he was Head of Corporate Development leading the M&A activities. He was also a member of the Executive Committee. Prior to that he held positions in ICI, Medeva, Celltech and UCB in various business development and supply chain roles. He is a board member of several of the Flerie portfolio companies both in drug development and commercial growth sectors. He has a first degree in Industrial Studies from Nottingham Trent University and an MBA from the Open Business School.

He enjoys the outdoors and in particular walking in the English Lake District is a lifelong fan of Formula One.

 

Mark on Linkedin

flerie-thomas-people

Thomas Eldered

Executive Chairman

Thomas Eldered

Thomas is executive chairman of Flerie since January 2023. He was the founder of Flerie in 2011 and was for more than a decade the sole shareholder and investor. Before that he co-founded the CDMO Recipharm in 1995, led the IPO in 2014 and finally left the company early 2021 when it was taken private again. Thomas is board member or chairman of the board in several portfolio companies. He holds a MSc in Industrial and Management Engineering from Linköping University.

Thomas enjoys hiking, cross country skiing and learning about other cultures.

 

Thomas on Linkedin

flerie-karl-people-v

Karl Elmqvist

Investment Manager

Karl Elmqvist

Karl is an Investment Manager at Flerie. He currently serves as a board member in portfolio company Strike Pharma and is an observer in AnaCardio. Karl is a medical doctor by training, obtaining his MBBS BSc from Imperial College London where he also spent a year at the business school. He has previously worked as a doctor at St Thomas’ Hospital, part of Guy’s and St Thomas’ NHS Foundation Trust in London. Prior to that he was at a Swedish digital health start-up in product and commercial roles.

 

Karl on Linkedin

Gunilla Rydquist

Office Manager

Gunilla Rydquist

Gunilla joined Flerie in August 2021 as Office Manager. She has 30+ years of experience as Executive Assistant, Management Team and Board of Directors administration, and in Travel Management within the pharma companies Pharmacia, Recip and Recipharm.

She enjoys traveling and spending time in the countryside.

Carl-Johan Spak

Senior Advisor

Carl-Johan Spak

Carl-Johan is a senior advisor at Flerie since April 2021. He has held several positions in pharma companies and has served as director in Flerie companies since 2012. He currently serves as director of several drug development and medtech companies, among them KAHR Medical, Atrogi Symcel, EpiEndo and Xspray Pharma.

Until 2021, Carl-Johan had a long career within Recipharm, one of the leading CDMOs in the pharma space, where he started in 1995. He holds a PhD in pharmacology and cariology from the Karolinska Institute in Sweden.

Carl-Johan enjoys mountain biking, especially in Lofsdalen, Sweden together with family life with his grandchildren.

 

Carl-Johan on Linkedin

flerie-carlos-people

Carlos von Bonhorst

Senior Advisor

Carlos von Bonhorst

Carlos joined Flerie in 2022 as a senior advisor. He is an MD (Lisbon, 1981) but has worked with pharmaceutical companies for more than 40 years, either as executive or as advisor to boards in several countries. He worked in business and corporate development director positions in Biofarma and Helsinn and was a member of the board of Recipharm.

In 1994 Carlos moved from Switzerland to Belgium, where he continues to work as an independent consultant to international pharmaceutical companies, governments, and institutions as an expert in pharma and biotech innovation. He is a member of the jury of the EIC and evaluator of several European research and innovation programs. He owns a technology transfer company.

Carlos enjoys the arts: music (in particular opera and indie rock) and modern painting. He is an enthusiastic reader and loves long strolls on sunny beaches.

 

Carlos on Linkedin

Michaela Gertz

Senior Advisor

Michaela Gertz

Michaela is a senior advisor since August 2022. She has previously been CFO for the Nasdaq-listed biotech companies Immunicum and PledPharma, as well as held roles within fundraising and investor relations at Accelerator Nordic and ITP Invest. In addition to being a senior advisor at Flerie, she is a self-employed consultant working with CFO support, financing, IPOs and board assignments mostly in pharma/biotech. Michaela holds a MSc in Business and Economics from Uppsala University.

She enjoys travelling, playing golf and spending time in the archipelago.

 

Michaela on Linkedin